| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.2 | 2e-05 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |